Delivery Order SPE2DB22D1103-SPE2DB24FTSB7

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,427.44 firm fixed-price delivery order is for the supply of 4565214603 OLOPATADINE HCL 0.1% EYE DROPS 5ML, with a final completion date of July 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Olopatadine Hydrochloride 0.1% eye drops. The $1,297.14 delivery order is a firm-fixed price contract with an ultimate completion date of April 24, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,534.59 Firm Fixed Price Delivery Order is for the provision of OLOPATADINE HCL 0.1% EYE DROPS 5ML to support federal healthcare programs. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp maintains a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,696.26 delivery order contract is for the supply of Olopatadine HCl 0.1% eye drops. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,935.80 firm fixed-price delivery order is for the supply of Olopatadine HCl 0.1% eye drops in 5ml bottles. The contract has an ultimate completion date of September 15, 2022 and was awarded on September 14, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,424.20 delivery order is for the supply of Olopatadine HCL 0.1% eye drops in 5ml containers. The contract has a firm fixed price pricing type and an ultimate completion date of October 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award, valued at $2,115.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Olopatadine Hydrochloride 0.1% eye drops, a specialty medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine HCl 0.1% eye drops. The contract has a ceiling value of $2,252.93 and is a firm fixed price delivery order with a period of performance through March 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,310.09, is for the delivery of Olopatadine HCl 0.1% eye drops in 5ml vials. The contract is a delivery order type with a firm fixed price pricing structure, and the ultimate completion date is December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,308.39, is for the delivery of OLOPATADINE HCL 0.1% eye drops in 5ml quantities. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTSB7
    Delivery Order

This federal contract award, identified as SPE2DB22D1103|SPE2DB24FTSB7, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,017.56 firm-fixed-price delivery order is for the supply of OLOPATADINE HCL 0.1% EYE DROPS 5ML, a pharmaceutical product. This award is not set aside for any specific business type.

Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024. These IDCs enable the company to efficiently provide a comprehensive range of essential medical commodities, including prescription drugs and medical supplies, to support various federal healthcare programs and facilities nationwide.

Generated 12/26/24, 9:04 AM